CD4 and rheumatoid arthritis: To determine whether the CD4+ T cell response to SARS-CoV-2 vaccination in individuals with RA was impaired compared with controls, we stimulated PBMCs overnight with a pool of peptides from the SARS-CoV-2 S protein, then stained the cells with a T cell activation-induced marker (AIM) flow cytometry panel.